‘Landmark’ pancreatic cancer drug keeps patients alive for twice as long - The Washington Post

‘Landmark’ pancreatic cancer drug keeps patients alive for twice as long    The Washington Post After new drug’s ‘unprecedented’ results for pancreatic cancer, doctors look at other uses    NBC News A standing ovation for RevMed, and caution for Akeso    statnews.com New drug nearly doubles survival rates in some pancreatic cancer patients, study says    CBS News Daily pill can double survival time for world’s deadliest cancer, trial shows    The Guardian

Original source: Google News IR